Gene Therapy using anti-inflammatory cytokines promising against MS

15 January 2018

BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach against multiple sclerosis (MS).

Leave a Reply

Your email address will not be published. Required fields are marked *